Colchicine has full FDA approval to treat heart disease, even for primary prevention.
It works by lowering arterial inflammation.
Louis notes that the FDA approved low-dose colchicine to reduce cardiovascular events, working by lowering arterial inflammation. Per the Medscape report, it is the first specific anti-inflammatory drug for this purpose in people with established atherosclerotic disease or multiple risk factors.
Colchicine has full FDA approval to treat heart disease, even for primary prevention.
It works by lowering arterial inflammation.
Please note that the drug has been approved even for primary prevention with multiple risk factors.